Current Report Filing (8-k)
03 Februar 2020 - 2:18PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Form
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): February 3, 2020
|
BiomX
Inc.
|
|
|
(Exact
Name of Registrant as Specified in its Charter)
|
|
Delaware
|
|
0001-38762
|
|
82-3364020
|
(State
or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S.
Employer
Identification No.)
|
7
Pinhas Sapir St., Floor 2
Ness Ziona, Israel
|
|
7414002
|
(Address
of Principal Executive Offices)
|
|
(Zip
Code)
|
Registrant’s
telephone number, including area code: +972 723942377
|
n/a
|
|
|
(Former
name or former address, if changed since last report)
|
|
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
|
☐
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
☐
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
☐
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
☐
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class
|
|
Trading
Symbol(s)
|
|
Name
of each exchange on which registered
|
Units,
each consisting of one share of Common Stock, $0.0001 par value, and one Warrant entitling the holder to receive one half
share of Common Stock
|
|
PHGE.U
|
|
NYSE
American
|
Shares
of Common Stock, $0.0001 par value, included as part of the Units
|
|
PHGE
|
|
NYSE
American
|
Warrants
included as part of the Units
|
|
PHGE.WS
|
|
NYSE
American
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item
7.01 Regulation FD Disclosure.
On
February 3, 2020, BiomX Inc. (the “Company”) issued a press release announcing that the Company’s
securities will be listed for trading on the Tel Aviv Stock Exchange effective February 6, 2020. A copy of the press release is
attached as Exhibit 99.1 to this Current Report on Form 8-K.
The
information in this report is being furnished, not filed, pursuant to Regulation FD. Accordingly, the information in Items 7.01
and 9.01 of this report will not be incorporated by reference into any registration statement filed by the Company under the Securities
Act of 1933, as amended, unless specifically identified as being incorporated therein by reference. The furnishing of the information
in this report is not intended to, and does not, constitute a determination or admission by the Company that the information in
this report is material or complete, or that investors should consider this information before making an investment decision with
respect to any security of the Company or any of its affiliates.
Item
9.01. Financial Statements and Exhibits.
(d)
Exhibits
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
BIOMX
INC.
|
|
|
|
February 3, 2020
|
By:
|
/s/
Jonathan Solomon
|
|
|
Name:
|
Jonathan Solomon
|
|
|
Title:
|
Chief
Executive Officer
|
2
BiomX (AMEX:PHGE.U)
Historical Stock Chart
Von Nov 2024 bis Dez 2024
BiomX (AMEX:PHGE.U)
Historical Stock Chart
Von Dez 2023 bis Dez 2024
Echtzeit-Nachrichten über BiomX Inc (Amerikanische Börse): 0 Nachrichtenartikel
Weitere Biomx Inc. News-Artikel